Department of Community Medicine, College of Medicine, University of Nigeria, Enugu-campus, Nigeria.
BMC Public Health. 2010 Aug 16;10:486. doi: 10.1186/1471-2458-10-486.
Rapid diagnostic tests (RDTs) and Artemisinin-based combination therapy (ACT) have been widely advocated by government and the international community as cost-effective tools for diagnosis and treatment of malaria. ACTs are now the first line treatment drug for malaria in Nigeria and RDTs have been introduced by the government to bridge the existing gaps in proper diagnosis. However, it is not known how readily available these RDTs and ACTs are in public and private health facilities and whether health workers are actually using them. Hence, this study investigated the levels of availability and use of RDTs and ACTs in these facilities.
The study was undertaken in Enugu state, southeast Nigeria in March 2009. Data was collected from heads of 74 public and private health facilities on the availability and use of RDTs and ACTs. Also, the availability of RDTs and the types of ACTs that were available in the facilities were documented.
Only 31.1% of the health facilities used RDTs to diagnose malaria. The majority used the syndromic approach. However, 61.1% of healthcare providers were aware of RDTs. RDTs were available in 53.3% of the facilities. Public health facilities and health facilities in the urban areas were using RDTs more and these were mainly bought from pharmacy shops and supplied by NGOs. The main reasons given for non use are unreliability of RDTs, supply issues, costs, preference for other methods of diagnosis and providers' ignorance. ACTs were the drug of choice for most public health facilities and the drugs were readily available in these facilities.
Although many providers were knowledgeable about RDTs, not many facilities used it. ACTS were readily available and used in public but not private health facilities. However, the reported use of ACTs with limited proper diagnosis implies that there could be high incidence of inappropriate case management of malaria which can also increase the economic burden of illnesses. Government and donors should ensure constant availability of RDTs in both public and private facilities, so that every treatment with ACTs is accompanied with proper diagnosis.
快速诊断检测(RDT)和青蒿素为基础的联合疗法(ACT)已被政府和国际社会广泛倡导为经济有效的疟疾诊断和治疗工具。ACT 现在是尼日利亚的一线抗疟药物,政府已经引入了 RDT,以弥补正确诊断方面的现有差距。然而,目前尚不清楚这些 RDT 和 ACT 在公共和私人卫生机构中是否容易获得,以及卫生工作者是否实际在使用它们。因此,本研究调查了这些设施中 RDT 和 ACT 的供应和使用情况。
本研究于 2009 年 3 月在尼日利亚东南部的埃努古州进行。数据是从 74 家公共和私人卫生机构的负责人那里收集的,内容涉及 RDT 和 ACT 的供应和使用情况。还记录了这些设施中 RDT 的供应情况和可用的 ACT 类型。
只有 31.1%的卫生机构使用 RDT 来诊断疟疾。大多数机构采用综合征方法。然而,61.1%的卫生保健提供者了解 RDT。RDT 仅在 53.3%的设施中可用。公共卫生机构和城市地区的卫生机构更频繁地使用 RDT,这些 RDT 主要从药店购买,并由非政府组织供应。不使用 RDT 的主要原因是其不可靠、供应问题、成本、对其他诊断方法的偏好以及提供者的无知。ACT 是大多数公共卫生机构的首选药物,这些药物在这些机构中很容易获得。
尽管许多提供者了解 RDT,但没有多少机构使用它。ACT 在公共卫生机构中很容易获得和使用,但在私人卫生机构中并非如此。然而,据报道,在缺乏适当诊断的情况下使用 ACT 意味着可能存在大量不适当的疟疾病例管理,这也会增加疾病的经济负担。政府和捐助者应确保 RDT 在公共和私人设施中都能持续供应,以便在使用 ACT 治疗时都能进行适当的诊断。